When compared with Thailand, the seroprevalence of hepatitis A virus (HAV) is extremely high among its neighbouring countries. To investigate the seroprevalence of HAV among the Thai people residing in the border area between Thailand and Myanmar, 308 residents in Umphang, Maesod district, Tak, were recruited. Sera were tested for HAV IgG antibodies by enzyme-linked immunosorbent assay. The overall seroprevalence among the Thai people residing in the border area of Thailand was significantly higher than that among the general Thai population (71% vs 27% respectively, p<0.05). As asymptomatic or mild HAV infection typically occurs in children, the Thai people residing in the border area may receive little benefit from universal HAV vaccin...
Hepatitis A virus (HAV) and hepatitis E virus (HEV) infection in developing countries are associated...
Hepatitis A virus (HAV) infection is common in developing countries. An accurate incidence of HAV in...
Despite hepatitis B vaccination at birth and at 6, 10 and 14 weeks of age, hepatitis B virus (HBV) i...
When compared with Thailand, the seroprevalence of hepatitis A virus (HAV) is extremely high among i...
We report the results of seroepidemiological study of hepatitis E virus (HEV) infection in 636 volun...
Introduction: Thailand has integrated hepatitis B (HB) vaccination of newborns into the national Exp...
Hepatitis A virus (HAV) is transmitted via the fecal-oral route from contaminated food or water. As ...
Abstract Objective This study aimed to determine the seroprevalence of anti-HAV IgG in Thai medical ...
Abstract. Hepatitis A virus (HAV) infection is common in Southeast Asia, and most of the inhabitants...
SummaryObjectiveTo estimate the number of people living in Thailand with chronic hepatitis B (CHB), ...
Objective: To estimate the number of people living in Thailand with chronic hepatitis B (CHB), a maj...
Despite several recent reports of outbreaks of hepatitis A, little is known about the disease burden...
Objective: To estimate the number of people living in Thailand with chronic hepatitis B (CHB), a maj...
Abstract. Sera from 269 Hmong people (102 males and 167 females, with mean age 35.4 years, range 16-...
Background Vaccination remains the mainstay of prevention of hepatitis B virus (HBV) including birth...
Hepatitis A virus (HAV) and hepatitis E virus (HEV) infection in developing countries are associated...
Hepatitis A virus (HAV) infection is common in developing countries. An accurate incidence of HAV in...
Despite hepatitis B vaccination at birth and at 6, 10 and 14 weeks of age, hepatitis B virus (HBV) i...
When compared with Thailand, the seroprevalence of hepatitis A virus (HAV) is extremely high among i...
We report the results of seroepidemiological study of hepatitis E virus (HEV) infection in 636 volun...
Introduction: Thailand has integrated hepatitis B (HB) vaccination of newborns into the national Exp...
Hepatitis A virus (HAV) is transmitted via the fecal-oral route from contaminated food or water. As ...
Abstract Objective This study aimed to determine the seroprevalence of anti-HAV IgG in Thai medical ...
Abstract. Hepatitis A virus (HAV) infection is common in Southeast Asia, and most of the inhabitants...
SummaryObjectiveTo estimate the number of people living in Thailand with chronic hepatitis B (CHB), ...
Objective: To estimate the number of people living in Thailand with chronic hepatitis B (CHB), a maj...
Despite several recent reports of outbreaks of hepatitis A, little is known about the disease burden...
Objective: To estimate the number of people living in Thailand with chronic hepatitis B (CHB), a maj...
Abstract. Sera from 269 Hmong people (102 males and 167 females, with mean age 35.4 years, range 16-...
Background Vaccination remains the mainstay of prevention of hepatitis B virus (HBV) including birth...
Hepatitis A virus (HAV) and hepatitis E virus (HEV) infection in developing countries are associated...
Hepatitis A virus (HAV) infection is common in developing countries. An accurate incidence of HAV in...
Despite hepatitis B vaccination at birth and at 6, 10 and 14 weeks of age, hepatitis B virus (HBV) i...